menu
    • menu

    Company profile for Evaluate Pharma

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EvaluatePharma® is the leader in consensus forecasts of leading industry analysts and analysis of the pharmaceutical and biotechnology healthcare sectors providing exclusive and trusted market intelligence into global performance to 2024.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Evaluate Pharmaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Evaluate Ltd., 11-29 Fashion Street, London E1 6PX United Kingdom
    Telephone
    Telephone
    +44 (0)20 7377 0800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.evaluate.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/intent/user?screen_name=evaluatepharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Big Pharma regained mojo in 2022 but biotechs remain precarious
    Big Pharma regained mojo in 2022 but biotechs remain precarious

    03 Mar 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/big-pharma-regained-mojo-last-year-biotech-valuations-remain-precarious-report

    James Waldron FIERCE BIOTECH
    03 Mar 2023
    Share Share
    The potential blockbusters still awaiting FDA decisions in 2021
    The potential blockbusters still awaiting FDA decisions in 2021

    13 Sep 2021

    // FIERCEPHARMA

    https://www.fiercepharma.com/pharma/from-pfizer-to-argenx-a-look-at-potential-blockbusters-awaiting-fda-decisions-to-close-out

    FIERCEPHARMA
    13 Sep 2021
    Share Share
    MMIT and Evaluate merge to become a $ 1.6 billion pharmaceutical market provider
    MMIT and Evaluate merge to become a $ 1.6 billion pharmaceutical market provider

    29 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210829005009/ja

    BUSINESSWIRE
    29 Aug 2021
    Share Share
    Who's getting the most out of their R&D engine? Pharma's top 11, ranked
    Who's getting the most out of their R&D engine? Pharma's top 11, ranked

    26 Aug 2021

    // Fraiser Kansteiner FIERCE PHARMA

    https://www.fiercepharma.com/special-report/who-s-getting-most-out-their-r-d-engine-pharma-s-top-11-ranked

    Fraiser Kansteiner FIERCE PHARMA
    26 Aug 2021
    Share Share
    Top 11 most valuable R&D engines in pharma
    Top 11 most valuable R&D engines in pharma

    24 Aug 2021

    // Fraiser Kansteiner FIERCEPHARMA

    https://www.fiercepharma.com/special-report/who-s-getting-most-out-their-r-d-engine-pharma-s-top-11-ranked

    Fraiser Kansteiner FIERCEPHARMA
    24 Aug 2021
    Share Share
    Which pharma's getting the most out of its new drug approvals?
    Which pharma's getting the most out of its new drug approvals?

    23 Aug 2021

    // FIERCE PHARMA

    https://www.fiercepharma.com/special-report/who-s-getting-most-out-their-r-d-engine-pharma-s-top-11-ranked

    FIERCE PHARMA
    23 Aug 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search